MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development
暂无分享,去创建一个
Lee A D Cooper | Margaret A. Johns | Yuhong Du | Haian Fu | Fadlo R Khuri | Sahar Harati | F. Khuri | L. Cooper | C. Moreno | H. Fu | Yuhong Du | Sahar Harati | A. Ivanov | J. D. Moran | F. Giuste | Carlos S Moreno | Josue D Moran | Felipe O Giuste | Andrei A Ivanov | Margaret A Johns
[1] D. Longo,et al. Linking β-Catenin to Androgen-signaling Pathway* , 2002, The Journal of Biological Chemistry.
[2] K. Ha,et al. Mechanisms underlying TGF‐β1‐induced expression of VEGF and Flk‐1 in mouse macrophages and their implications for angiogenesis , 2007, Journal of leukocyte biology.
[3] Jing Chen,et al. NDEx, the Network Data Exchange. , 2015, Cell systems.
[4] Yun-Wei Lin,et al. Inhibition of p38 MAPK-Dependent Excision Repair Cross-Complementing 1 Expression Decreases the DNA Repair Capacity to Sensitize Lung Cancer Cells to Etoposide , 2011, Molecular Cancer Therapeutics.
[5] Jon C. Aster,et al. Network analysis of gene essentiality in functional genomics experiments , 2015, Genome Biology.
[6] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[7] F. Staal,et al. Wnt signaling in leukemias and myeloma: T-cell factors are in control. , 2013, Future oncology.
[8] Hakho Lee,et al. Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis , 2015, Cell.
[9] C. Heldin,et al. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. , 2005, Molecular and cellular biology.
[10] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[11] Pradip De,et al. Wnt signaling in triple negative breast cancer is associated with metastasis , 2013, BMC Cancer.
[12] J. Christensen,et al. Preclinical Development Activation of IL-6 R / JAK 1 / STAT 3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non – Small Cell Lung Cancer with T 790 M Resistance Mutation , 2012 .
[13] Michael Peyton,et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells , 2007, Nature.
[14] Xiangyin Kong,et al. Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach , 2015, BioMed research international.
[15] J. Christensen,et al. Activation of IL-6R/JAK1/STAT3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation , 2012, Molecular Cancer Therapeutics.
[16] A. Marcus,et al. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers , 2016, Oncotarget.
[17] T. Macdonald,et al. A functional role for Smad7 in sustaining colon cancer cell growth and survival , 2014, Cell Death and Disease.
[18] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] Ellen T. Gelfand,et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies , 2014, Scientific Data.
[20] Paul Workman,et al. Distinctive Behaviors of Druggable Proteins in Cellular Networks , 2015, PLoS Comput. Biol..
[21] B. Mao,et al. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance , 2016, Chinese journal of cancer.
[22] R. Nusse,et al. Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] Jiahuai Han,et al. p38γ regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage , 2010, Protein & Cell.
[24] István A. Kovács,et al. Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders , 2015, Cell.
[25] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[26] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[27] F. Khuri,et al. Targeting protein-protein interactions as an anticancer strategy. , 2013, Trends in pharmacological sciences.
[28] Randall T. Moon,et al. The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. , 2000, The Journal of cell biology.
[29] Reuven Agami,et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.
[30] M. Vidal,et al. Edgetic perturbation models of human inherited disorders , 2009, Molecular systems biology.
[31] Hui Zhang,et al. TGFβ signaling in pancreatic ductal adenocarcinoma , 2015, Tumor Biology.
[32] C. Tse,et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. , 2008, Cancer research.
[33] Michael Peyton,et al. Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer , 2013, Cell.
[34] M. Kahn,et al. Safely targeting cancer stem cells via selective catenin coactivator antagonism , 2014, Cancer science.
[35] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[36] J. Mesirov,et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer , 2011, Proceedings of the National Academy of Sciences.
[37] Dihua Yu,et al. Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit , 2011, Oncogene.
[38] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[39] A. Khwaja,et al. Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemia , 2005, Oncogene.
[40] Jeffrey R. Whiteaker,et al. Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.
[41] Sergey Brin,et al. Reprint of: The anatomy of a large-scale hypertextual web search engine , 2012, Comput. Networks.
[42] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[43] C. Moreno,et al. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells , 2013, Journal of Translational Medicine.
[44] Hyeong Jun An,et al. Estimating the size of the human interactome , 2008, Proceedings of the National Academy of Sciences.
[45] M. Schlissel,et al. Activation of p38 MAP kinase by DNA double‐strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint , 2006, The EMBO journal.
[46] C. Roberts,et al. Vulnerabilities of mutant SWI/SNF complexes in cancer. , 2014, Cancer cell.
[47] Fengzhu Sun,et al. A network-based integrative approach to prioritize reliable hits from multiple genome-wide RNAi screens in Drosophila , 2009, BMC Genomics.
[48] E. Shimizu,et al. Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing tyrosine kinase inhibitors in small cell lung cancer cells: implication of c-Src and its inhibitor. , 2009, International journal of oncology.
[49] G. Ganji,et al. BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models , 2013, PloS one.
[50] C. Heldin,et al. Interaction between Smad7 and β-Catenin: Importance for Transforming Growth Factor β-Induced Apoptosis , 2005, Molecular and Cellular Biology.
[51] Jenny J. Li,et al. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas , 2015, Front. Oncol..
[52] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[53] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[54] K. Wisinski,et al. Role of the androgen receptor in triple-negative breast cancer. , 2016, Clinical advances in hematology & oncology : H&O.
[55] W. Hahn,et al. ARID1B is a specific vulnerability in ARID1A-mutant cancers , 2014, Nature Medicine.
[56] C. Schaefer,et al. Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction , 2011, Oncogene.
[57] K. Matsumoto,et al. Phosphorylation of the retinoblastoma protein by cdk2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Potter,et al. Genetic Variations in SMAD7 Are Associated with Colorectal Cancer Risk in the Colon Cancer Family Registry , 2013, PloS one.
[59] René Bernards,et al. An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors , 2006, Nature chemical biology.
[60] W. Isaacs,et al. In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis , 2002, Oncogene.
[61] E. Schadt,et al. Integrating siRNA and protein-protein interaction data to identify an expanded insulin signaling network. , 2009, Genome research.
[62] Pablo Tamayo,et al. ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens , 2013, Genome research.
[63] W. Hahn,et al. ARID1B is a specific vulnerability in ARID1A-mutant cancers , 2014, Nature Medicine.
[64] E. Llamosas,et al. Wnt signalling in gynaecological cancers: A future target for personalised medicine? , 2016, Gynecologic oncology.
[65] Jih-Hsiang Lee,et al. The Janus Kinases Inhibitor AZD1480 Attenuates Growth of Small Cell Lung Cancers In Vitro and In Vivo , 2013, Clinical Cancer Research.
[66] R. Beroukhim,et al. BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma , 2013, Clinical Cancer Research.
[67] L. Vassilev,et al. Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma. , 2005, Blood.
[68] Jill P. Mesirov,et al. β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis , 2012, Cell.
[69] Khalique Newaz,et al. Identification of Major Signaling Pathways in Prion Disease Progression Using Network Analysis , 2015, PloS one.